Hicks, Blánaid M <br/><br/>
Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink.  [electronic resource] 

 -  BMJ (Clinical research ed.)  Oct 2016 
 - i5340 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-1833 
<br/><br/><label>Standard No.: </label>10.1136/bmj.i5340  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Breast Neoplasms--chemically induced<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl-Peptidase IV Inhibitors--adverse effects<br/>Female<br/>Glucagon-Like Peptide 1--analogs & derivatives<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Middle Aged<br/>Risk Factors<br/>Time Factors<br/>United Kingdom--epidemiology